2025年 新着論文 28 病態シグナル学分野から論文が発表されました
Necl-4/CADM4 regulates GABAergic synaptic strength on GABAergic inhibitory neurons via ErbB4 activation and prevents neuronal impairments
- PMID: 40728771
- DOI: 10.1007/s12035-025-05230-8
Abstract
Neural networks comprise excitatory and inhibitory neurons, linked through excitatory and inhibitory synapses. Synaptic excitation/inhibition balance is controlled for brain development and functions, and its dysregulations are implicated in aging-dependent neuronal impairments. Here, we found that Necl-4/CADM4, an immunoglobulin superfamily cell adhesion molecule, is expressed in γ-aminobutyric acidergic (GABAergic) inhibitory neurons and localizes at GABAergic synapses on inhibitory neurons in cultured hippocampal neurons and the mouse hippocampus. Necl-4 genetic ablation induced neuronal loss with synaptic degenerations in the hippocampus, and cultured Necl-4-knockout (KO) hippocampal neurons were more susceptible to death. Prior to the neuronal death, the Necl-4-KO hippocampal neurons showed an increase in GABAergic synapse density on inhibitory neurons and in synaptic molecules at GABAergic synapses on inhibitory neurons, which were regulated by ErbB4 activation. Furthermore, electrophysiological analysis revealed that Necl-4 genetic ablation enhanced GABAergic synaptic currents on inhibitory neurons and induced high-frequency firing in dissociated hippocampal cultures composed of glutamatergic excitatory neurons and inhibitory neurons, contributing to excitotoxicity-mediated neuronal death. Thus, Necl-4 regulates GABAergic synaptic strength on inhibitory neurons via ErbB4 activation and prevents neuronal impairments.
Keywords: ErbB4; GABA receptor; GABAergic synapses; Inhibitory neuron; Necl-4/CADM4; Neuronal impairments.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics Approval: All animal experiments were performed in accordance with institutional guidelines and approved by the administrative panel on laboratory animal care of Kobe University. This study was approved by the president of Kobe University after being reviewed by the Kobe University Animal Care and Use Committee (approval No. 30–06-01, 30–07-01, and P230506), and animal experiments were conducted in accordance with regulations for animal experimentation of Kobe University. Competing Interests: Michinori Koebis is currently employed at Eisai Co. All the other authors declare that they have no competing interests.